IBM is releasing the AI tools it developed in order to help researchers and medical professionals better understand the underlying processes of COVID-19. The AI tools consist of aggregated data, which relate to potential therapeutic materials, as well as sequenced genomes of SARS-CoV-2. The new AI data set will be able to empower the front-line personnel involved in developing treatments for the virus.
IBM will also be releasing its Functional Genomics Platform for free until the pandemic has subsided. The Functional Genomics Platform is a cloud research tool related to respiratory genes, as well as proteins and other viral and bacterial materials.
Currently, IBM has found 3,000 new molecules that could serve as potential therapies for the virus.
Virus Research AI Tools
IBM is Releasing Its AI Tools to Researchers and Medical Personnel
Trend Themes
1. AI Tools for Virus Research - Leveraging AI tools in virus research can accelerate the understanding of COVID-19 and aid in the development of treatments.
2. Functional Genomics Platform - The release of the Functional Genomics Platform allows researchers to study respiratory genes and viral materials, contributing to a better understanding of the virus.
3. Identifying Potential Therapies - Discovering 3,000 new molecules as potential therapies showcases the potential of advanced technology in finding effective treatment options for the virus.
Industry Implications
1. Healthcare - The healthcare industry can utilize AI tools and functional genomics platforms to enhance virus research and improve patient treatments.
2. Pharmaceutical - Pharmaceutical companies can explore the identified molecules as potential therapies and leverage AI tools for accelerated drug discovery.
3. Technology - The technology industry can provide AI solutions and platforms that empower researchers and medical professionals in their fight against the virus.